Purchases and Sales Made in Q1 2024 in Pyxis Oncology, Inc. (PYXS)
This table provides information about the institutional ownership of Pyxis Oncology, Inc. (PYXS) during Q1 2024. The information is specifically focused on institutions that hold shares of Pyxis Oncology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jul 22, 2024
Q1 2024
|
Harbour Investments, Inc.
Madison, WI |
BUY
|
- |
581New |
$1.18K - $3.83K
|
581
$662
|
|
|
May 10, 2024
Q1 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
485+ 18.4% |
$985 - $3.2K
|
3.12K
$3.56K
|
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 10, 2024
Q1 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-1.7K- 67.05% |
$3.44K - $11.2K
|
834
$951
|
|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-4.59K- 15.21% |
$9.32K - $30.3K
|
25.6K
$29.2K
|
|
|
May 15, 2024
Q1 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-4.7K- 1.99% |
$9.54K - $31K
|
231K
$264K
|
|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-21.5K- 97.72% |
$43.6K - $142K
|
500
$570
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-39.1K- 47.31% |
$79.3K - $258K
|
43.5K
$49.6K
|
|
|
May 15, 2024
Q1 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-48.6K- 75.7% |
$98.7K - $320K
|
15.6K
$17.8K
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-103K- 96.15% |
$209K - $677K
|
4.11K
$4.68K
|
|
|
May 13, 2024
Q1 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-216K- 59.36% |
$439K - $1.42M
|
148K
$169K
|
|
|
May 14, 2024
Q1 2024
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-326K- 78.44% |
$661K - $2.15M
|
89.5K
$102K
|